Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pulmatrix (PULM) Shares Outstanding (Weighted Average) (2016 - 2025)

Pulmatrix (PULM) has disclosed Shares Outstanding (Weighted Average) for 13 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.0% to $3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $3.7 million for FY2025, 581.61% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $3.7 million in Q4 2025 for Pulmatrix, roughly flat from $3.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $3.5 billion in Q3 2022 to a low of $5548.0 in Q3 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $517.3 million across 5 years, with a median of $3.7 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): soared 131315.08% in 2022 and later crashed 100.0% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $2.7 million in 2021, then soared by 127189.17% to $3.4 billion in 2022, then tumbled by 99.89% to $3.7 million in 2023, then rose by 0.01% to $3.7 million in 2024, then changed by 0.0% to $3.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for PULM at $3.7 million in Q4 2025, $3.7 million in Q3 2025, and $3.7 million in Q2 2025.